NCT06291038View on ClinicalTrials.gov

Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

March 1, 2029

Study Completion Date

March 1, 2029

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

• Experimental group: treatment with glutamine at a dose of 5g 3 times a day for 8 weeks

treatment with glutamine at a dose of 5g 3 times a day for 8 weeks

DIETARY_SUPPLEMENT

• Control group: treatment with a protein powder (Protifar) (Placébo) 5g 3 times a day for 8 weeks.

treatment with a protein powder (Protifar) (Placébo) 5g 3 times a day for 8 weeks.

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT06291038 - Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability | Biotech Hunter | Biotech Hunter